[Use of the combination of proscillaridine A, thioridazine and glucose-1-phosphate in the treatment of senile cardiopathies].
D000368:Aged; D002018:Bufanolides / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy; D004338:Drug Combinations; D005947:Glucose / Q000627:therapeutic use*; D005958:Glucosephosphates / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006600:Hexosephosphates / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D013881:Thioridazine / Q000627:therapeutic use*
D002018:Bufanolides; D004338:Drug Combinations; D005958:Glucosephosphates; D006600:Hexosephosphates; D005947:Glucose; D013881:Thioridazine
L'impiego dell'associazione proscillaridina A, tioridazina e glucosio-1-fosfato nella terapia delle cardiopatie senili.